PharmAla To Be Exclusive MDMA Supply Partner To Awakn Life Sciences

Effective immediately, MDXX class molecules producer PharmAla Biotech Holdings Inc. will become the exclusive MDMA supplier to Awakn Life Sciences (OTCMKTS: AWKNF).

“We’ve been working with the Awakn team for several months now, to ensure they have all the material needed for their development efforts,” said PharmAla’s CEO Nick Kadysh. He added that both companies “share a bit of founding history,” referring to Prof. David Nutt, founding board member of PharmAla who left the board to become Awakn’s CRO. In this sense, he says, it’s “completely fitting” to become Awakn’s supplier of both engineering-grade and GMP LaNeo MDMA towards growing its R&D program. 

Awakn CEO Anthony Tennyson said that …

Full story available on